Pathway Background and Objectives

Over the years, the increase in resistance to typical antibiotics has changed the approach to the management of skin and soft tissue infections (SSTIs) in children. In 2014, the Infectious Disease Society of America (IDSA) updated their SSTIs guidelines. Based on these changes and also our local antimicrobial data, we have applied these recommendations to provide a consistent approach to treatment of children with these infections.

The specific objectives of this pathway are to:

  • Outline the management of SSTIs depending on severity of infection
  • Recommend tailored antibiotic therapy based on culture results
  • Recommend oral options for intravenous antibiotics

Algorithm  Educational Module

 

  • Percentage of eligible patients with SSTI order set usage (for admitted patients only)
  • Percentage of patients who receive the recommended antibiotics per pathway
  • Percentage of patients who receive the appropriate dosage of antibiotics per pathway
  • Percentage of patients prescribed 5-10 total course of antibiotic therapy
  • Average length of stay (days) for patients admitted with SSTI
  • Percentage of patients readmitted within 7 days of discharge
  • Hassan El Chebib, MD
  • Grace Hong, APRN
  • Jennifer Girotto, PharmD

The clinical pathways in the above links have been developed specifically for use at Connecticut Children’s and are made available publicly for informational and/or educational purposes only. The clinical pathways are not intended to be, nor are they, a substitute for individualized professional medical judgment, advice, diagnosis, or treatment. Although Connecticut Children’s makes all efforts to ensure the accuracy of the posted content, Connecticut Children’s makes no warranty of any kind as to the accuracy or completeness of the information or its fitness for use at any particular facility or in any individual case.